{"@id":"https://bioecon.ru/technology/formulation-development-drug-product/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://bioecon.ru/technology/formulation-development-drug-product/","json":"https://bioecon.ru/api/v1/technology/formulation-development-drug-product/index.json"},"id":"formulation-development-drug-product","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/formulaciones-quimicas-sa/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/visjon-biologics/","https://bioecon.ru/companies/klk-oleo/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/china-resources-pharmaceutical/","https://bioecon.ru/companies/insilico-medicine/"]},"maturity":9,"name":"Разработка и оптимизация инъекционных лекарственных форм биопрепаратов","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Высокопроизводительный биофизический скрининг"},{"n":2,"title":"Стресс-тестирование и ускоренная деградация"},{"n":3,"title":"Совместимость с первичной упаковкой"},{"n":4,"title":"Фиксация коммерческой рецептуры"}],"summary":"Биофизическая платформа формулирования биопрепаратов (QbD), оптимизирующая жидкие и лиофилизированные формы моноклональных антител и белков во флаконах и шприцах.","url":"/technology/formulation-development-drug-product/","verified":"2026-11-22"}